You just read:

D-Pharm Completes Recruitment of Patients into the first Dosage Tier of its Phase 2 Study with THR-18 in Acute Stroke Patients Treated with tPA

News provided by

D-Pharm Ltd

Jan 21, 2014, 08:00 ET